<DOC>
	<DOCNO>NCT00391001</DOCNO>
	<brief_summary>Recently , McLean hospital conduct 4 month taurine study show reduction mania rating . As follow-up preliminary taurine study , complementary currently ongoing double-blind , placebo-controlled trial taurine adult bipolar disorder , study target adolescent bipolar subject ( type I ) symptom mania mixed mania . To knowledge , would first study evaluate effect novel compound taurine adolescent subject bipolar disorder . We hypothesize positive response adolescent taurine treatment , positive response great expect chance . This study may demonstrate taurine well-tolerated effective adjunct treatment mania bipolar disorder .</brief_summary>
	<brief_title>Taurine Adolescents With Bipolar Disorder</brief_title>
	<detailed_description>A cohort adolescent ( age 13-18 ) patient bipolar disorder current manic symptom approach participation 3-month outpatient study . Taurine match placebo administer orally , capsule , add whatever medication ( ) patient receive clinician . The specific medication dosage determine solely subject ' non-study clinician ( `` treatment-as-usual '' ) . During 3 month study , subject require keep medication nearly constant ( minor dosage adjustment side-effects maintain therapeutic level permit ) duration trial . Since taurine adjunctive therapy , patient currently take mood stabilizer continue . The research team work closely subject outpatient clinician ( ) coordinate medication issue . The result standard rating scale bipolar disorder research compare group receive taurine group receive placebo . The sample include thirty adolescent ( age 13-18 ) outpatient bipolar disorder , type I . The study 3 month long . Study Drugs : The cohort randomize receive either taurine matching placebo ( microcellulose ) . Taurine placebo provide 500 mg vegetable capsule . Follow-up visit clinical rating : During baseline visit , detailed psychiatric medical history obtain . The adolescent start study medicine time . The following standard rating scale perform : 1 . Kiddie Schedule Affective Disorders Schizophrenia School-Age Children-Present Lifetime Episode ( K-SADS-PL ) additional mood onset offset item derive WASH-U K-SADS ( K-SADS-PL-W ) ( Kaufman 1997 ) . 2 . Young Mania Rating Scale ( YMRS ; 11 item structure interview ; Young et al 1978 ) . 3 . Children 's Depression Rating Scale - Revised ( CDRS-R ; Overholser 1995 ) . 4 . The ADHD Rating Scale ( ARS-IV ; DuPaul 1998 ) . 5 . Clinical Global Impression scale - Bipolar version ( CGI-BP ; Guy 1976 ) . 6 . Children 's Global Assessment Scale ( CGAS ; Shaffer 1995 ) . 7 . Montgomery-Asberg Depression rating Scale ( MADRS ; Montgomery &amp; Asberg 1979 ) . 8 . Brief Adverse Effect Rating Scale . 9 . Brief Psychiatric Rating Scale Children ( BPRS-C ; Overall &amp; Pfefferbaum 1982 ) . 10 . Safety Assessment ( derive group 's ongoing treatment study ) . After baseline evaluation , subject evaluate every week 1 month , every 2 week remainder 3 month . The rating scale perform follow-up visit , except KSADS-PL-W ARS-IV . Instead full KSADS-PL-W follow-up visit , screen question mania depression perform order aid determination syndromic recovery recurrence . In addition , patient maintain daily Mood Diary , review study visit elicit symptom recall . All rating perform blind study personnel , know whether patient receive taurine placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Subjects must meet DSMIVTR criterion bipolar disorder ( type I ) , current hypomania , mania , mixed mania . Subjects must age 13 18 year . Medications ( `` treatmentasusual '' ) stable x2 week Subjects must able assent participation study . Subjects must agree avoid take supplemental taurine ( e.g . overthecounter preparation , energy drink , etc ) . Comorbid serious mental illness . Significant medical neurological illness , include : seizure disorder , severe respiratory illness cardiac condition , know cerebrovascular disease , hypo hypertension , diabetes mellitus , immune , endocrine , renal hepatic dysfunction ( study team wish enroll subject increase risk complication require additional clinical monitoring due medical illness ) . Pregnant subject . It known effect taurine supplementation would fetus . In addition , woman childbearing potential practice medically accept method contraception exclude . Patients , investigator 's judgment , pose current serious suicidal homicidal risk , patient likely able comply study protocol . Patients meet DSMIVTR criterion current substance abuse substance dependence . Patients regularly take supplemental taurine time screening .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>mania</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>taurine</keyword>
	<keyword>adolescent</keyword>
</DOC>